# AUVI-Q

NDC: 51662-1661
Generic name: AUVI-Q
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20121115

FDA application: NDA201739

## Active ingredients

- EPINEPHRINE: .1 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1661"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1661
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23e772f8-26d0-b516-e063-6394a90ada58